Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (21-30 of 493) with videos related to

Pageof 50
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1995
Effect of 1,10-phenanthroline on DNA binding by 1,25-(OH)2 vitamin D receptorK B Atkins, D C Beitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?Rupal S Bhatt, Michael B Atkins
Journal of Cancer Metastasis and Treatment|March 17, 2022
Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinomaMichael T Serzan, Michael B Atkins
Cancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M Tannir
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Phorbol ester stimulated cathepsin L expression in U937 cellsK B Atkins, B R Troen
Expert Opinion on Investigational Drugs|August 7, 2010
Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyondRyan J Sullivan, Michael B Atkins
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
New agents and new targets for renal cell carcinomaGeorge K Philips, Michael B Atkins
Cancer Medicine|January 10, 2014
PD-1 as a potential target in cancer therapyDavid F McDermott, Michael B Atkins
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Emerging clinical issues in melanoma in the molecularly targeted eraRyan J Sullivan, Michael B Atkins
Journal for Immunotherapy of Cancer|August 27, 2025
How can we increase the value of clinical trials with immunotherapy?Michael B Atkins, David F Mcdermott
Pageof 50

Showing results (21-30 of 493) with videos related to

Sort By:
Pageof 50
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1995
Effect of 1,10-phenanthroline on DNA binding by 1,25-(OH)2 vitamin D receptorK B Atkins, D C Beitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?Rupal S Bhatt, Michael B Atkins
Journal of Cancer Metastasis and Treatment|March 17, 2022
Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinomaMichael T Serzan, Michael B Atkins
Cancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M Tannir
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Phorbol ester stimulated cathepsin L expression in U937 cellsK B Atkins, B R Troen
Expert Opinion on Investigational Drugs|August 7, 2010
Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyondRyan J Sullivan, Michael B Atkins
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
New agents and new targets for renal cell carcinomaGeorge K Philips, Michael B Atkins
Cancer Medicine|January 10, 2014
PD-1 as a potential target in cancer therapyDavid F McDermott, Michael B Atkins
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Emerging clinical issues in melanoma in the molecularly targeted eraRyan J Sullivan, Michael B Atkins
Journal for Immunotherapy of Cancer|August 27, 2025
How can we increase the value of clinical trials with immunotherapy?Michael B Atkins, David F Mcdermott
Pageof 50